Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us About Us
Newsroom Press News Features Events Contact Media Relations TOP PRESS RELEASES
01/04/2019 Adaptive Biotechnologies to Enter Into Worldwide Collaboration and
License Agreement with Genentech to Develop Personalized Cellular Therapies
for the Treatment of Cancer 01/03/2019 Adaptive Biotechnologies to Present at
the 37th Annual J.P. Morgan Healthcare Conference 09/28/2018 FDA Grants De
Novo Designation for Adaptive Biotechnologies’ clonoSEQ Assay to Detect and
Monitor Minimal Residual Disease (MRD) in Patients with Multiple Myeloma and
Acute Lymphoblastic Leukemia LATEST PRESS RELEASES 10/27/2016 Adaptive
Biotechnologies Announces the Inclusion of NGS-Based MRD Assessment in the
NCCN Clinical Practice Guidelines for Multiple Myeloma 08/23/2016 Adaptive
Biotechnologies Provides Open-Access to the Deepest Immunosequencing Dataset
of Unique B-cell Receptors (BCRs) for Immunology Research 06/10/2016 Adaptive
Biotechnologies and Collaborators to Present Data Demonstrating High-
Throughput Sequencing for Minimal Residual Disease (MRD) is More Sensitive
than Flow Cytometry and Can Be Used as a Determinant of Early Response to
Therapy 06/04/2016 Adaptive Biotechnologies and Collaborators to Present Seven
Studies Demonstrating the Use of Immunosequencing to Identify Prognostic
Biomarkers and Potential Biomarkers of Response at the 2016 American Society
of Clinical Oncology Annual Meeting 05/14/2016 Adaptive Biotechnologies to
Present 2 Studies Demonstrating Utility of Immunosequencing to Propel
Diagnostic Development and Therapeutic Discovery at the 2016 American
Association of Immunologists Annual Meeting 04/16/2016 Adaptive
Biotechnologies and Collaborators to Present 10 Studies Demonstrating the
Utility of Immunosequencing in Both Tissue and Blood Samples at 2016 American
Association of Cancer Research Annual Meeting 04/11/2016 Adaptive
Biotechnologies Welcomes Charles Sang as Senior Vice President of Diagnostics
03/15/2016 Innovation Leader, Diego Miralles, M.D., Joins Adaptive
Biotechnologies as President of Adaptive Therapeutics 01/08/2016 Pfizer Enters
into Translational Research Collaboration with Adaptive Biotechnologies to
Help Advance Novel Immuno-Oncology Solutions Previous 1 2 3 4 … 15 Next TOP
NEWS FEATURES 01/04/2019 Genentech: A New Age for Neoantigens 01/03/2019
Microsoft Blog: Every immune system has a story to tell; the key is knowing
how to listen 05/09/2018 T Cell Receptor Sequencing IDs Aggressive Lymphoma
Subtype LATEST NEWS FEATURES 06/27/2016 The Immune Repertoire Comes Into Focus
06/22/2016 T-Cell Receptor Sequencing Reveals Novel Biomarkers For Ovarian
Cancer 06/12/2016 Dr. Jakubowiak on Improved Efficacy with ASCT+ KRd in
Multiple Myeloma 06/03/2016 The 15 Most Popular Unicorn Startups Per Industry
05/31/2016 Gov. Jay Inslee: June 1 is Life Sciences Day in Washington
05/31/2016 Treatment ‘breakthrough’ in man with advanced skin cancer
05/11/2016 What Is MRD Testing for Myeloma and Why Should It Be Used?
05/05/2016 Chad Robins Selected as Finalist for the EY Entrepreneur Of The
Year® 2016 Award in the Pacific Northwest 05/05/2016 EY announces 21 Pacific
Northwest finalists for 2016 Entrepreneur of the Year Previous 1 2 3 4 … 11
Next TOP EVENTS 01/03/2019 J.P. Morgan Healthcare Conference 2019 12/01/2018
ASH 2018 LATEST EVENTS 04/24/2018 immunoSEQ Seminar: Accelerating
Immunomodulatory Therapy Discovery with Quantitative Adaptive Immune Profiling
04/16/2018 British Society for Hematology 04/14/2018 AACR Annual Meeting 2018
04/10/2018 immunoSEQ Seminar: Accelerating Discovery and Innovation with
Immunosequencing 03/28/2018 Life Science Innovation NW 03/18/2018 Keystone
Cancer: Combinations 03/18/2018 Keystone Cancer: Combinations 01/28/2018
Keystone Symposia on Translational Systems Immunology d-none d-sm-block
Previous 1 2 3 Contact media relations phone (917) 912-7195 email
media@adaptivebiotech.com Corporate/Research (855) 466-8667 Diagnostics (888)
522-8988 Immune Profiling PlatformPlatform Overview Publications Products &
ServicesLIFE SCIENCES RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ®
Pipeline DRUG DISCOVERY Cellular Therapy Vaccines PartnershipsCancer Cellular
Therapy Antigen Map Biopharma Partnerships Strategic Collaborators About UsOur
Story Culture Careers News & Events Contact Us © Adaptive Biotechnologies. All
Rights Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy
HIPAA Policy Code of Conduct Patents & Trademarks Licenses